Member Info for Digittt

Because he specifically said to 100 of us that we have no partner on COVID.

Agreed...all that he was saying with that tweet is we are still working with EL (not on their COVID meds), but agreed, if I was a betting man I'd suggest he was trying to stoke FOMF in his shareholders. Oh wait...we're all betting men...or women.

He's cautious in giving news as he learnt his lesson 3 years ago when he tweeted "A serious breakthrough in the lab" and pushed the SP to 6p. He was put on the naughty step then...well I assume he was.

The fun only really starts at 25%...

Shareholding of 5% or more
- Able to require the circulation of a written resolution.
- Able to require the company to call a general meeting.
- Able to prevent the deemed re-appointment of an auditor.

Shareholding of 10%
- Able to call a poll vote at a general meeting.
- Able to require an audit.

Shareholding greater than 10%
- Able to block consent to short notice of a general meeting.

Shareholding greater than 25%
- Able to block a special resolution.
- Able to block compromise arrangement with members or a class of members.

Fold is such a bad choice of word....!

1.2m for me.

Fear of Missing Friday.

Pin the Thread so we can go through it if we want to...no need to keep reposting!!

Zowie, Bowie. Would have thought a humble hands in the air, yeah I interpreted it wrong would have been fine, but clearly this is a sensitive topic for you.

JHFH is using lingo that is used throughout the investment world by institutions and private individuals alike, no mal-intent or snideness in it.

My buy of 20,000 tells me the reporting is out.

Pacha - happy days. I know you couched your comment vav paper profits, but current price puts me back in the paper position I was 2 years ago...having subsequently lost almost half of my portfolio by being overweight on 2 other risk bets that went pop. Very grateful to be on paper where we are now, but plenty of scars. Not sure the mice can be used to treat scars, but the paper profits are definitely soothing.

That a thing you've learnt from your time in France?

I'll be around the corner from their virtual / registered offices in London next week...I'll go check to see if there's as much tumble-weed in their offices as there is in their external comms.

Not a bank holiday in the US.

Coincidentally the number I hold as well. I've said this before, but I think if you tot up the various significant holdings touted on the board we must hold a decent amount of the free float shares.

Thanks Pingu - very informative.

Agree chances are likely higher, but trying to calibrate as everyone talks as if so much is practically a foregone conclusion. Chances are higher, so does that mean a 3 in 10 chance?

I've been in the share 3 years or so...wouldn't fancy having to wait another 2, but perhaps that's how long we might have to wait to have any chance of the $bn valuations others have been touting.

Bogyo - I seem to recall you saying you work in a giant pharma...do you have any insight to offer on success rates for pre-clinical pharma trials?

Solow, thanks very much, very helpful.

JHFH - (Without a pharma background) I have to temper your commentary a bit. CDX has been proven it works to that point. There's a reason for clinical trials and the continuation thereafter. Question is what's the failure rate for a similar product from the point we are at currently. I have no idea but I shy away from everyone going slam dunk it absolutely works...the money's in the bank, let's all go on holiday. Does anyone have some stats to throw out on clinical trial failure rates etc?